Antares Pharma (ATRS) Prices 12.5M Offering at $4/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Antares Pharma (ATRS) Dips on New Equity Offering
October 2, 2012 5:02 PM EDTAntares Pharma, Inc. (Nasdaq: ATRS) shares are lower after the company announced a new equity raise, trading about 8 percent lower late Tuesday.
Below is the release:
[Antares Pharma] announced a public offering of shares of its common stock. This... More
